Patent Assignment
Reel/Frame 075851/0089
Security Interest
Recorded: 2026-08-31
Pages: 9
Assignors
BIOXCEL THERAPEUTICS, INC.
Executed: 2026-08-31
ONKOSXCEL THERAPEUTICS, LLC
Executed: 2026-08-31
Assignee
OAKTREE FUND ADMINISTRATION, LLC
333 S. GRAND AVENUE, 28TH FLOOR, LOS ANGELES, CALIFORNIA, 90071
Covered Properties
(26)
Methods for Treating Depressive States
Application:
18/574,404 →
Publication:
US US20250319069A1
Prevention or Treatment of Sleep Disorders Using Dexmedetomidine Formulation
Application:
18/634,242 →
Publication:
US US20250099430A1
Methods and Compositions for Treating Agitation
Application:
18/812,515 →
Publication:
US US20250228833A1
Use of Sublingual Dexmedetomidine for the Treatment of Agitation
Application:
18/967,863 →
Publication:
US US20250325521A1
Non-Sedating Dexmedetomidine Treatment Regimens
Application:
19/046,879 →
Publication:
US US20260000650A1
Dexmedetomidine Treatment Regimens
Application:
18/940,419 →
Publication:
US US20250302808A1
Novel Approach for Treatment of Cancer Using Immunomodulation
Application:
18/802,908 →
Publication:
US US20250213681A1
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Use of Sublingual Dexmedetomidine for the Treatment of Agitation
Predictive and Diagnostic Methods for Prostate Cancer
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Use of Sublingual Dexmedetomidine for the Treatment of Agitation
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Use of Sublingual Dexmedetomidine for the Treatment of Agitation
Non-Sedating Dexmedetomidine Treatment Regimens
Patent:
11,806,334 →
Application:
18/153,870 →
Non-Sedating Dexmedetomidine Treatment Regimens
Patent:
11,998,528 →
Application:
18/189,073 →
Non-Sedating Dexmedetomidine Treatment Regimens
Non-Sedating Dexmedetomidine Treatment Regimens
Non-Sedating Dexmedetomidine Treatment Regimens
Non-Sedating Dexmedetomidine Treatment Regimens
Non-Sedating Dexmedetomidine Treatment Regimens
Non-Sedating Dexmedetomidine Treatment Regimens
Approach for Treatment of Cancer via Immunomodulation by Using Talabostat
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 8, 2019
From: NANDABALAN, KRISHNAN; RASTELLI, LUCA
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 049689/0674 →
Assignment of Assignor's Interest
Aug 12, 2019
From: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 050021/0158 →
Assignment of Assignor's Interest
Aug 12, 2019
From: KAKUMANU, VASUKUMAR
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 050021/0151 →
Assignment of Assignor's Interest
Aug 12, 2019
From: HANLEY, DAVID CHRISTIAN; YOCCA, FRANK; LATHIA, CHETAN DALPATBHAI
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 050021/0123 →
Assignment of Assignor's Interest
Aug 12, 2019
From: BARNHART, SCOTT DAVID
To: ARX, LLC
Reel/Frame 050021/0186 →
Assignment of Assignor's Interest
Nov 11, 2019
From: YOCCA, FRANK
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 050970/0177 →
Assignment of Assignor's Interest
Nov 11, 2019
From: BIOXCEL CORPORATION
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 050970/0209 →
Assignment of Assignor's Interest
Nov 11, 2019
From: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 050970/0333 →
Assignment of Assignor's Interest
Nov 11, 2019
From: SHARMA, SAMEER
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 050970/0327 →
Assignment of Assignor's Interest
Nov 11, 2019
From: NANDABALAN, KRISHNAN
To: BIOXCEL CORPORATION
Reel/Frame 050970/0190 →
Assignment of Assignor's Interest
Jul 17, 2020
From: HANLEY, DAVID CHRISTIAN; YOCCA, FRANK; LATHIA, CHETAN DALPATBHAI
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 053242/0187 →
Assignment of Assignor's Interest
Jul 17, 2020
From: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 053242/0808 →
Assignment of Assignor's Interest
Jul 17, 2020
From: KAKUMANU, VASUKUMAR
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 053242/0768 →
Assignment of Assignor's Interest
Jul 17, 2020
From: BARNHART, SCOTT DAVID
To: ARX, LLC
Reel/Frame 053242/0257 →
Assignment of Assignor's Interest
Nov 24, 2020
From: HANLEY, DAVID CHRISTIAN; YOCCA, FRANK; LATHIA, CHETAN DALPATBHAI
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 054460/0332 →
Assignment of Assignor's Interest
Nov 24, 2020
From: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 054460/0414 →
Assignment of Assignor's Interest
Nov 24, 2020
From: BARNHART, SCOTT DAVID
To: ARX, LLC
Reel/Frame 054460/0460 →
Assignment of Assignor's Interest
Nov 24, 2020
From: KAKUMANU, VASUKUMAR
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 054514/0629 →
Corrective Assignment to Correct the Signature Page by Assignee (Correcting Assignee Name to Ez Bioxcel Solutions Pvt. Ltd. Rather Than Bioxcel Therapeutics, Inc. Previously Recorded on Reel 050021 Frame 0151. Assignor(S) Hereby Confirms the Correct Assignee Name for Signature Is Ez Bioxcel Solutions Pvt. Ltd.
Jan 12, 2021
From: KAKUMANU, VASUKUMAR
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 054976/0212 →
Assignment of Assignor's Interest
Jan 20, 2022
From: KAKUMANU, VASUKUMAR
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 058786/0542 →
Assignment of Assignor's Interest
Jan 20, 2022
From: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 058711/0772 →
Assignment of Assignor's Interest
Jan 20, 2022
From: HANLEY, DAVID CHRISTIAN; YOCCA, FRANK; LATHIA, CHETAN DALPATBHAI
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 058711/0548 →
Assignment of Assignor's Interest
Jan 20, 2022
From: BARNHART, SCOTT DAVID
To: ARX, LLC
Reel/Frame 058711/0943 →
Assignment of Assignor's Interest
Jan 24, 2022
From: KAKUMANU, VASUKUMAR
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 058827/0698 →
Assignment of Assignor's Interest
Jan 24, 2022
From: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 058746/0296 →